Legal & General Group PLC Cytokinetics Inc Transaction History
Legal & General Group PLC
- $357 Billion
- Q1 2025
A detailed history of Legal & General Group PLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Legal & General Group PLC holds 177,881 shares of CYTK stock, worth $5.69 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
177,881
Previous 178,632
0.42%
Holding current value
$5.69 Million
Previous $8.4 Million
14.91%
% of portfolio
0.0%
Previous 0.0%
Shares
34 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$470 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$379 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$319 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$256 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$195 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.01B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...